Analysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in Zambia

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Torpey, Kwasi ^a   Mandala, Justin ^a   Kasonde, Prisca ^a   Bryan Mofya, Gail ^b   Bweupe, Maximillian ^c   Mukundu, Jonathan ^a   Zimba, Chilunje ^a   Mwale, Catherine ^a   Lumano, Hilary ^b   Welsh, Michael ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b MANAGEMENT SCIENCES FOR HEALTH   (United States)

^c MINISTRY OF HEALTH   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NEVIRAPINE; VIRUS DNA; ZIDOVUDINE;

ADULT; AGE DISTRIBUTION; BREAST FEEDING; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA DETERMINATION; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MOTHER CHILD RELATION; OBSERVATIONAL STUDY; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; REVIEW; RISK REDUCTION; SINGLE DRUG DOSE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ZAMBIA;

ADULT; AGE DISTRIBUTION; ANTI-HIV AGENTS; DELIVERY, OBSTETRIC; EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MATERNAL EXPOSURE; ZAMBIA;

EID: 84865092892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042859     Document Type: Review

References (29)

1. UNAIDS (2011) World AIDS Day Report. Geneva.
2. Black RE, Morris SS, Bryce J, (2003) Where and why are 10 million children dying every year? Lancet 361: 2226-2234.
3. WHO, UNAIDS, UNICEF (2010) Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector. Progress report. Geneva.
4. UNICEF, WHO, UNAIDS, Medecine VSo (2009) Consultative Meeting on Evaluating the Impact of Prevention of Mother-To-Child Transmission of HIV (PMTCT) Services in Low- and Middle-Income Countries in Averting New HIV Infections in Children and Improving Child Survival. Nashville, Tennessee, USA.
5. Stringer EM, Chi BH, Chintu N, Creek TL, Ekouevi DK, et al. (2008) Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. Bull World Health Organ 86: 57-62.
6. Torpey K, Kasonde P, Kabaso M, Weaver MA, Bryan G, et al. (2010) Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr 54: 415-422.
7. Torpey K, Kabaso M, Weaver MA, Kasonde P, Mukonka V, et al. (2011) Infant Feeding Options, Other Nonchemoprophylactic Factors, and Mother-to-Child Transmission of HIV in Zambia. J Int Assoc Physicians AIDS Care (Chic) 11: 26-33.
8. Zambia (2010) National Protocol Guidelines for Integrated Prevention of Mother to Child Transmission of HIV. Lusaka, Zambia: Ministry of Health.
9. WHO (2010) Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach. Geneva.
10. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, et al. (2000) Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 283: 1175-1182.
11. Rollins N, Little K, Mzolo S, Horwood C, Newell ML, (2007) Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS 21: 1341-1347.
12. Coetzee D, Hilderbrand K, Boulle A, Draper B, Abdullah F, et al. (2005) Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ 83: 489-494.
13. Sherman GG, Jones SA, Coovadia AH, Urban MF, Bolton KD, (2004) PMTCT from research to reality-results from a routine service. S Afr Med J 94: 289-292.
14. Malyuta R, Newell ML, Ostergren M, Thorne C, Zhilka N, (2006) Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. Eur J Public Health 16: 123-127.
15. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, et al. (1999) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354: 795-802.
16. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, et al. (2003) A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 187: 725-735.
17. Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, et al. (2005) Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 19: 309-318.
18. Creek T, Tanuri A, Smith M, Seipone K, Smit M, et al. (2008) Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission. Pediatr Infect Dis J 27: 22-26.
19. WHO (2010) PMTCT Strategic Vision 2010-2015. Preventing mother-to-child transmissionof HIV to reach the UNGASS and Millenium Development Goals. Moving towards the Elimination of Pediatric HIV. Geneva.
20. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, et al. (2006) Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 296: 794-805.
21. de Vincenzi I, (2011) Group KBS (2011) Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis 11: 171-180.
22. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, et al. (2008) Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 359: 119-129.
23. Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, et al. (2008) Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372: 300-313.
24. WHO, UNAIDS, UNFPA, UNICEF (2010) Guidelines on HIV and Infant Feeding. Principles and recommendations for infant feeding in the context of HIV and a summary of evidence.
25. WHO (2012) Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Programatic Update. Geneva.
26. Ostergaard LR, Bula A, (2010) "They call our children "Nevirapine babies?"": A qualitative study about exclusive breastfeeding among HIV positive mothers in Malawi. Afr J Reprod Health 14: 213-222.
27. Maru S, Datong P, Selleng D, Mang E, Inyang B, et al. (2009) Social determinants of mixed feeding behavior among HIV-infected mothers in Jos, Nigeria. AIDS Care 21: 1114-1123.
28. Matovu A, Kirunda B, Rugamba-Kabagambe G, Tumwesigye NM, Nuwaha F, (2008) Factors influencing adherence to exclusive breast feeding among HIV positive mothers in Kabarole district, Uganda. East Afr Med J 85: 162-170.
29. Msuya SE, Mbizvo EM, Hussain A, Uriyo J, Sam NE, et al. (2008) Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs. AIDS Care 20: 700-709.